J. L. OTT
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 5
- Pharmacology 12
- Microbial Natural Products and Biosynthesis 7
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- F. T. COUNTER (14 shared papers)Manuel Debono (7 shared papers)D. S. Fukuda (4 shared papers)R. NAGARAJAN (2 shared papers)John L. Occolowitz (2 shared papers)Herbert A. Kirst (7 shared papers)C. H. Werkman (3 shared papers)Robert L. Hamill (2 shared papers)
- Journals
- The Journal of Antibiotics (14 papers)Journal of Medicinal Chemistry (6 papers)Antimicrobial Agents and Chemotherapy (2 papers)Archives of Biochemistry and Biophysics (2 papers)Journal of Bacteriology (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
J. L. OTT
29 papers receiving 683 citations
Peers
Comparison fields: 5 of 76
- Microbiology 135
- Molecular Medicine 105
- Pharmacology 332
- Toxicology 28
- Biotechnology 67
Countries citing papers authored by J. L. OTT
This map shows the geographic impact of J. L. OTT's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. OTT with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. OTT more than expected).
Fields of papers citing papers by J. L. OTT
This network shows the impact of papers produced by J. L. OTT. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. OTT. The network helps show where J. L. OTT may publish in the future.
Co-authors
The 25 scholars most cited alongside J. L. OTT, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 169 | |
| 2 | 1989 | 83 | |
| 3 | 1989 | 60 | |
| 4 | 1990 | 55 | |
| 5 | 1990 | 45 | |
| 6 | 1988 | 37 | |
| 7 | 1982 | 36 | |
| 8 | 1985 | 36 | |
| 9 | 1988 | 35 | |
| 10 | 1962 | 32 | |
| 11 | 1962 | 20 | |
| 12 | 1979 | 18 | |
| 13 | 1957 | 16 | |
| 14 | 1975 | 16 | |
| 15 | 1989 | 15 | |
| 16 | 1960 | 14 | |
| 17 | 1954 | 13 | |
| 18 | 1986 | 11 | |
| 19 | 1971 | 9 | |
| 20 | 1987 | 9 |
About J. L. OTT
J. L. OTT is a scholar working on Molecular Biology, Pharmacology, Microbiology, Organic Chemistry and Molecular Medicine, having authored 29 papers that have together received 775 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Microbial Natural Products and Biosynthesis (7 papers), Antimicrobial Peptides and Activities (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Microbial infections and disease research (3 papers), Synthesis of β-Lactam Compounds (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Microbiology (135 citations), Molecular Medicine (105 citations), Pharmacology (332 citations), Toxicology (28 citations) and Biotechnology (67 citations). J. L. OTT has collaborated with scholars based in United States and Japan. Frequent co-authors include F. T. COUNTER, Manuel Debono, D. S. Fukuda, R. NAGARAJAN, John L. Occolowitz, Herbert A. Kirst, C. H. Werkman, Robert L. Hamill, Robert M. Molloy and Ann H. Hunt. Their work appears in journals such as The Journal of Antibiotics, Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Archives of Biochemistry and Biophysics and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.